Author Archives: Ben Comer

Following Industry, OPDP Hopes to Eliminate Silos in Ad Review

By Ben Comer | Published: March 8, 2013
The Office of Prescription Drug Promotion (OPDP) is reorganizing its two primary advertising review divisions – professional and consumer – in an attempt to stay in line with the silo-breaking, multi-channel promotional output pouring in from pharma. The line between physician marketing and consumer marketing has blurred as the facets of a brand campaign – from [...]
Posted in Advertising, E-Media, FDA, Legal, Marketing, Patient Communication, Regulatory, Sales, compliance, patient education, social media | Tagged , , , | Leave a comment

ePharma Summit: Turning Big Data into Better Content

By Ben Comer | Published: March 6, 2013
Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?
Posted in Advertising, E-Media, Events, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, Technology, healthcare, multimedia, social media | Tagged , , , , | Leave a comment

Getting it Done in Washington

By Ben Comer | Published: February 13, 2013
During his fifth State of the Union address, President Obama struck many familiar chords – including a line about ending certain subsidies to pharmaceutical companies – and emphasized, repeatedly, the need to get things done on the policy front. Will the sequestration drum beat goad members of the 113th Congress onto the dance floor?
Posted in Legal, R&D, Strategy, healthcare, pricing | Tagged , , , , , , , | Leave a comment

Patients on the Picket Line

By Ben Comer | Published: February 5, 2013
Good science can’t be rushed, even when the lives of patients hang in the balance. But regulatory science, and its relationship to a drug’s commercial success or failure, can inadvertently block access to individual patients in their hour of need.
Posted in Biotech, FDA, Legal, Market Access, Regulatory, Safety, healthcare | Tagged , , , , , , , , , , , , | Leave a comment

Five Compliance Questions to Ask Yourself, from the DOJ

By Ben Comer | Published: January 31, 2013
At CBI’s 10th Annual Pharmaceutical Compliance Congress, Maame Ewusi-Mensah Frimpong, deputy assistant attorney general, consumer protection branch, civil division, at the US Department of Justice, said being compliant means understanding people, and their motivations. Frimpong said non-compliance boils down to a failure of individuals, and offered five questions for chief compliance officers to ask themselves [...]
Posted in Corporate Responsibility, Legal, Regulatory, Safety, Strategy, compliance, leadership | Tagged , , | Leave a comment